Detalhe da pesquisa
1.
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.
Clin Cancer Res
; 29(13): 2513-2524, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790412
2.
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment.
Clin Cancer Res
; 24(13): 3036-3045, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599411